Bailard Inc. Takes Position in Maximus, Inc. (NYSE:MMS)

Bailard Inc. bought a new stake in Maximus, Inc. (NYSE:MMS) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,500 shares of the health services provider’s stock, valued at approximately $214,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. increased its position in Maximus by 1.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 716,501 shares of the health services provider’s stock worth $60,086,000 after purchasing an additional 8,702 shares in the last quarter. Assenagon Asset Management S.A. increased its position in Maximus by 151.6% during the 2nd quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock worth $19,980,000 after purchasing an additional 140,481 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Maximus during the 1st quarter worth approximately $2,601,000. Tidal Investments LLC increased its position in Maximus by 238.9% during the 1st quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider’s stock worth $1,071,000 after purchasing an additional 8,997 shares in the last quarter. Finally, Jump Financial LLC acquired a new position in Maximus during the 4th quarter worth approximately $1,048,000. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Maximus Price Performance

MMS stock opened at $92.31 on Wednesday. The company has a 50 day simple moving average of $88.79 and a 200 day simple moving average of $85.43. The stock has a market cap of $5.61 billion, a price-to-earnings ratio of 24.23 and a beta of 0.75. Maximus, Inc. has a 1 year low of $72.39 and a 1 year high of $93.97. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.53 and a quick ratio of 1.53.

Maximus (NYSE:MMS) last posted its earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share for the quarter, topping analysts’ consensus estimates of $1.47 by $0.27. Maximus had a net margin of 4.58% and a return on equity of 18.02%. The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period in the previous year, the firm posted $0.78 EPS. The company’s revenue for the quarter was up 10.6% compared to the same quarter last year. Research analysts anticipate that Maximus, Inc. will post 5.79 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th will be issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date is Thursday, August 15th. Maximus’s payout ratio is 31.50%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.